Lei Deng is an Oncology physician. OpenAlex indexes 188 publications with 5,027 citations (h-index 35); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Eastlake Ave E
Seattle, WA 981094405
Telephone
206-520-5000Provider last certified this registry record 29 Sept 2023.
Clinical trials
- Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year20251 payment
- Genentech, Inc.Program year20251 payment
- Tempus AI, IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
43.1%Corticosteroid43.1%Dexamethasone100%Part D≥14 patientsMetabolism & gastrointestinal
31.4%Serotonin-3 Receptor Antagonist31.4%Ondansetron Hcl100%Part D≥14 patientsNervous system
25.5%Phenothiazine25.5%Prochlorperazine Maleate100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Occlusal Force Maintains Alveolar Bone Homeostasis via Type H Angiogenesis
Journal of Dental Research
2023 - Transportation barriers, emergency room use, and mortality risk among US adults by cancer history
JNCI Journal of the National Cancer Institute
2023 - Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway
Clinical & Translational Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”